Utama › Kanser Pankreas › Minnesota › Rochester
Kajian klinikal Kanser Pankreas di Rochester, MN
22 kajian untuk Kanser Pankreas sedang mencari peserta di lokasi dalam dan sekitar Rochester (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma
Mengambil pesertaFasa 2
- Mayo Clinic in Rochester, Rochester
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Mengambil pesertaFasa 1
- Mayo Clinic Rochester, Rochester
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Mengambil pesertaKajian pemerhatian
- Mayo Clinic Rochester, Rochester
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Mengambil pesertaFasa 2/3
- Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
- Mayo Clinic, Rochester
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Mengambil pesertaFasa 3
- Mayo Clinic Cancer Center, Rochester
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Mengambil pesertaFasa 1/2
- Mayo Clinic, Rochester
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
Mengambil pesertaKajian pemerhatian
- Mayo Clinic in Rochester, Rochester
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Mengambil pesertaFasa 2
- Mayo Clinic Rochester, Rochester
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Mengambil pesertaFasa 2
- Local Institution - 0129, Rochester
- Local Institution - 0174, Rochester
- Local Institution - 0181, Rochester
Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis
Mengambil pesertaFasa 2
- Mayo Clinic in Rochester, Rochester
CREO - Microwave Ablation Feasibility Study
Mengambil peserta
- Mayo Clinic Rochester, Rochester
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Mengambil pesertaKajian pemerhatian
- Mayo Clinic in Rochester, Rochester
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Mengambil pesertaFasa 2
- Mayo Clinical Rochester, Rochester
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Mengambil pesertaFasa 1
- Mayo Clinic, Rochester
Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma
Mengambil pesertaFasa 2
- Mayo Clinic in Rochester, Rochester
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Mengambil pesertaFasa 1/2
- Mayo Clinic Rochester, Rochester
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Mayo Clinic in Rochester, Rochester
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
Mengambil pesertaKajian pemerhatian
- Mayo Clinic in Rochester, Rochester
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Mengambil pesertaFasa 2
- Ohio State University Telemedicine, Rochester
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Mayo Clinic, Rochester
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
Mengambil pesertaFasa 1/2
- Mayo Clinic, Rochester
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- Exelixis Clinical Site #14, Rochester
Kajian Kanser Pankreas di bandar lain
- Houston, TX61 kajian
- New York City, NY60 kajian
- Boston, MA43 kajian
- Nashville, TN39 kajian
- Los Angeles, CA35 kajian
- St. Louis, MO33 kajian
- Arlington, VA33 kajian
- Baltimore, MD31 kajian
- San Antonio, TX31 kajian
- Philadelphia, PA26 kajian
- Tampa, FL26 kajian
- Durham, NC24 kajian
Kajian lain di Rochester
- Kanser Payudara42 kajian
- Kanser Paru-paru Bukan Sel Kecil37 kajian
- Kanser Metastatik31 kajian
- Kanser (semua jenis)30 kajian
- Kanser Ovari29 kajian
- Kanser Kolorektal29 kajian
- Mieloma Pelbagai24 kajian
- Kegagalan Jantung22 kajian
- Kanser Prostat22 kajian
- Kanser Endometrium20 kajian
- Kanser Paru-paru20 kajian
- Leukemia Limfositik Kronik18 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.